Church & Dwight Brushes Off Orajel, Brushes Up Current Brand Support
This article was originally published in The Tan Sheet
Executive Summary
Church & Dwight has backed out of an agreement that gave the firm an option to purchase Del Labs'Orajel line in order to concentrate resources on its existing oral care lines, the firm announced Dec. 7
You may also be interested in...
Del OTC Acquisition Brings Orajel To Church & Dwight In $380 Million Deal
Church & Dwight agreed to acquire Del Pharmaceuticals' OTC brands, including the Orajel topical analgesic line, for $380 million in cash from Coty, Inc., the firm said April 1
Del Labs Announces Management Changes, New OTC Products
Del Labs former Chief Operating Officer Charles Hinkaty took the helm as president and CEO Aug. 19, succeeding retiring head William McMenemy
Church & Dwight Sinks Its Teeth Into Del Labs To Acquire Orajel
Church & Dwight will augment its oral care portfolio with the addition of Del Labs' Orajel topical analgesic brand under a proposed $465 mil. acquisition announced July 2